Olympus closes acquisition of Taewoong Medical for $370M

Olympus Corporation closed the acquisition of Taewoong Medical Co., Ltd., a Korean manufacturer of gastrointestinal metallic stents, for approximately $370 million in cash, with $255.5 million paid upfront and up to $114.5 million in milestone payments.

“Olympus Corporation today announced the closing of the acquisition of Taewoong Medical Co., Ltd, a Korea-based manufacturer of medical devices such as gastrointestinal (GI) metallic stents.”olympus-global.com

• 1 source
• olympus-global.comOlympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd, : 2024: News: OlympusJan 24, 2024

Summarized from public sources; check the original articles before acting on it.